2015-2025 Global Liposome Drug Delivery Market Research by Type, End-Use and Region

Publisher Name :
Date: 13-Jul-2020
No. of pages: 110

Summary

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.

The global Liposome Drug Delivery market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:

Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size

Chapter 2: Global Production & Consumption Market by Type and End-Use

Chapter 3: Europe Production & Consumption Market by Type and End-Use

Chapter 4: America Production & Consumption Market by Type and End-Use

Chapter 5: Asia Production & Consumption Market by Type and End-Use

Chapter 6: Oceania Production & Consumption Market by Type and End-Use

Chapter 7: Africa Production & Consumption Market by Type and End-Use

Chapter 8: Global Market Forecast by Type, End-Use and Region

Chapter 9: Company information, Sales, Cost, Margin, news etc.

Chapter 10: Market Competition by Companies and Market Concentration Ratio

Chapter 11: Market Impact by Coronavirus.

Chapter 12: Industry Summary

Ch

Market Segment as follows:

Key Companies

- Johnson & Johnson

- Gilead Sciences

- Pacira

- Sun Pharmaceutical

- Luye Pharma

- Sigma-Tau Group

- Teva Pharmaceutical

- Ipsen (Onivyde)

- Fudan-Zhangjiang

- CSPC

- Novartis

- Kingond Pharm

- Shanghai New Asia

- Spectrum Pharmaceuticals

Key Types

- Liposomal Doxorubicin

- Liposomal Amphoteracin B

- Liposomal Paclitaxel

- Liposomal Bupivacaine

- Other Liposomals

Key End-Use

- Fungal Infection Therapy

- Cancer & Tumor Therapy

- Others

This report can be dispatched within 24-48 Hours.

2015-2025 Global Liposome Drug Delivery Market Research by Type, End-Use and Region

Table of Contents

CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Liposome Drug Delivery Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Liposome Drug Delivery Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Liposome Drug Delivery Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Liposome Drug Delivery Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Liposome Drug Delivery Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaLiposome Drug Delivery Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Liposome Drug Delivery Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Liposome Drug Delivery Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Liposome Drug Delivery Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Liposome Drug Delivery Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Liposome Drug Delivery Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Liposome Drug Delivery Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Liposome Drug Delivery Revenue by Type, 2015-2020 (Million USD)
Figure Global Liposome Drug Delivery Revenue Share by Type in 2020 (Million USD)
Table Global Liposome Drug Delivery Production Volume by Type, 2015-2020 (Volume)
Figure Global Liposome Drug Delivery Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Liposome Drug Delivery Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Liposome Drug Delivery Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Liposome Drug Delivery Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Liposome Drug Delivery Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Liposome Drug Delivery Consumption Value by Region, 2015-2020 (Million USD)
Table Global Liposome Drug Delivery Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Liposome Drug Delivery Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Liposome Drug Delivery Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Liposome Drug Delivery Revenue by Type, 2015-2020 (Million USD)
Figure Europe Liposome Drug Delivery Revenue Share by Type in 2020 (Million USD)
Table Europe Liposome Drug Delivery Production Volume by Type, 2015-2020 (Volume)
Figure Europe Liposome Drug Delivery Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Liposome Drug Delivery Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Liposome Drug Delivery Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Liposome Drug Delivery Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Liposome Drug Delivery Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Liposome Drug Delivery Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Liposome Drug Delivery Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Liposome Drug Delivery Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Liposome Drug Delivery Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Liposome Drug Delivery Revenue by Type, 2015-2020 (Million USD)
Figure America Liposome Drug Delivery Revenue Share by Type in 2020 (Million USD)
Table America Liposome Drug Delivery Production Volume by Type, 2015-2020 (Volume)
Figure America Liposome Drug Delivery Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Liposome Drug Delivery Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Liposome Drug Delivery Consumption Value Share by End-Use in 2020 (Million USD)
Table America Liposome Drug Delivery Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Liposome Drug Delivery Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Liposome Drug Delivery Consumption Value by Region, 2015-2020 (Million USD)
Table America Liposome Drug Delivery Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Liposome Drug Delivery Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Liposome Drug Delivery Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Liposome Drug Delivery Revenue by Type, 2015-2020 (Million USD)
Figure Asia Liposome Drug Delivery Revenue Share by Type in 2020 (Million USD)
Table Asia Liposome Drug Delivery Production Volume by Type, 2015-2020 (Volume)
Figure Asia Liposome Drug Delivery Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Liposome Drug Delivery Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Liposome Drug Delivery Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Liposome Drug Delivery Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Liposome Drug Delivery Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Liposome Drug Delivery Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Liposome Drug Delivery Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Liposome Drug Delivery Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Liposome Drug Delivery Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Liposome Drug Delivery Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Liposome Drug Delivery Revenue Share by Type in 2020 (Million USD)
Table Oceania Liposome Drug Delivery Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Liposome Drug Delivery Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Liposome Drug Delivery Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Liposome Drug Delivery Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Liposome Drug Delivery Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Liposome Drug Delivery Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Liposome Drug Delivery Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Liposome Drug Delivery Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Liposome Drug Delivery Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Liposome Drug Delivery Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Liposome Drug Delivery Revenue by Type, 2015-2020 (Million USD)
Figure Africa Liposome Drug Delivery Revenue Share by Type in 2020 (Million USD)
Table Africa Liposome Drug Delivery Production Volume by Type, 2015-2020 (Volume)
Figure Africa Liposome Drug Delivery Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Liposome Drug Delivery Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Liposome Drug Delivery Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Liposome Drug Delivery Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Liposome Drug Delivery Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Liposome Drug Delivery Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Liposome Drug Delivery Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Liposome Drug Delivery Production Forecast
Figure Global Liposome Drug Delivery Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Liposome Drug Delivery Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Liposome Drug Delivery Forecast by Type
Table Global Liposome Drug Delivery Revenue by Type, 2020E-2025F (Million USD)
Figure Global Liposome Drug Delivery Revenue Share by Type in 2025 (Million USD)
Table Global Liposome Drug Delivery Production Volume by Type, 2020E-2025F (Volume)
Figure Global Liposome Drug Delivery Production Volume Share by Type in 2025 (Volume)
8.3 Global Liposome Drug Delivery Forecast by End-Use (2020E-2025F)
Table Global Liposome Drug Delivery Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Liposome Drug Delivery Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Liposome Drug Delivery Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Liposome Drug Delivery Forecast by Region (2020E-2025F)
Table Global Liposome Drug Delivery Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Liposome Drug Delivery Consumption Value Share by Region in 2025 (Million USD)
Table Global Liposome Drug Delivery Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Liposome Drug Delivery Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Johnson & Johnson
9.1.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
9.1.2 Johnson & Johnson Products & Services
9.1.3 Johnson & Johnson Company Dynamics & News
9.1.4 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Gilead Sciences
9.2.1 Gilead Sciences Profile
Table Gilead Sciences Overview List
9.2.2 Gilead Sciences Products & Services
9.2.3 Gilead Sciences Company Dynamics & News
9.2.4 Gilead Sciences Business Operation Conditions
Table Business Operation of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Pacira
9.3.1 Pacira Profile
Table Pacira Overview List
9.3.2 Pacira Products & Services
9.3.3 Pacira Company Dynamics & News
9.3.4 Pacira Business Operation Conditions
Table Business Operation of Pacira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Sun Pharmaceutical
9.4.1 Sun Pharmaceutical Profile
Table Sun Pharmaceutical Overview List
9.4.2 Sun Pharmaceutical Products & Services
9.4.3 Sun Pharmaceutical Company Dynamics & News
9.4.4 Sun Pharmaceutical Business Operation Conditions
Table Business Operation of Sun Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Luye Pharma
9.5.1 Luye Pharma Profile
Table Luye Pharma Overview List
9.5.2 Luye Pharma Products & Services
9.5.3 Luye Pharma Company Dynamics & News
9.5.4 Luye Pharma Business Operation Conditions
Table Business Operation of Luye Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Sigma-Tau Group
9.6.1 Sigma-Tau Group Profile
Table Sigma-Tau Group Overview List
9.6.2 Sigma-Tau Group Products & Services
9.6.3 Sigma-Tau Group Company Dynamics & News
9.6.4 Sigma-Tau Group Business Operation Conditions
Table Business Operation of Sigma-Tau Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Teva Pharmaceutical
9.7.1 Teva Pharmaceutical Profile
Table Teva Pharmaceutical Overview List
9.7.2 Teva Pharmaceutical Products & Services
9.7.3 Teva Pharmaceutical Company Dynamics & News
9.7.4 Teva Pharmaceutical Business Operation Conditions
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Ipsen (Onivyde)
9.8.1 Ipsen (Onivyde) Profile
Table Ipsen (Onivyde) Overview List
9.8.2 Ipsen (Onivyde) Products & Services
9.8.3 Ipsen (Onivyde) Company Dynamics & News
9.8.4 Ipsen (Onivyde) Business Operation Conditions
Table Business Operation of Ipsen (Onivyde) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Fudan-Zhangjiang
9.9.1 Fudan-Zhangjiang Profile
Table Fudan-Zhangjiang Overview List
9.9.2 Fudan-Zhangjiang Products & Services
9.9.3 Fudan-Zhangjiang Company Dynamics & News
9.9.4 Fudan-Zhangjiang Business Operation Conditions
Table Business Operation of Fudan-Zhangjiang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 CSPC
9.10.1 CSPC Profile
Table CSPC Overview List
9.10.2 CSPC Products & Services
9.10.3 CSPC Company Dynamics & News
9.10.4 CSPC Business Operation Conditions
Table Business Operation of CSPC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Novartis
9.11.1 Novartis Profile
Table Novartis Overview List
9.11.2 Novartis Products & Services
9.11.3 Novartis Company Dynamics & News
9.11.4 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Kingond Pharm
9.12.1 Kingond Pharm Profile
Table Kingond Pharm Overview List
9.12.2 Kingond Pharm Products & Services
9.12.3 Kingond Pharm Company Dynamics & News
9.12.4 Kingond Pharm Business Operation Conditions
Table Business Operation of Kingond Pharm (Sales Revenue, Cost, Gross Margin)
9.13 Shanghai New Asia
9.13.1 Shanghai New Asia Profile
Table Shanghai New Asia Overview List
9.13.2 Shanghai New Asia Products & Services
9.13.3 Shanghai New Asia Company Dynamics & News
9.13.4 Shanghai New Asia Business Operation Conditions
Table Business Operation of Shanghai New Asia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Spectrum Pharmaceuticals
9.14.1 Spectrum Pharmaceuticals Profile
Table Spectrum Pharmaceuticals Overview List
9.14.2 Spectrum Pharmaceuticals Products & Services
9.14.3 Spectrum Pharmaceuticals Company Dynamics & News
9.14.4 Spectrum Pharmaceuticals Business Operation Conditions
Table Business Operation of Spectrum Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Liposome Drug Delivery Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Liposome Drug Delivery Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Liposome Drug Delivery Sales Volume by Companies, 2015-2020E (Volume)
Table Global Liposome Drug Delivery Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Liposome Drug Delivery Market Concentration Ratio in 2020E
Figure America Liposome Drug Delivery Market Concentration Ratio in 2020E
Figure Asia Liposome Drug Delivery Market Concentration Ratio in 2020E
Figure Oceania Liposome Drug Delivery Market Concentration Ratio in 2020E
Figure Africa Liposome Drug Delivery Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Liposome Drug Delivery INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Liposome Drug Delivery INDUSTRY SUMMARY & CONCLUSION

List of Tables

Table Global Liposome Drug Delivery Revenue by Type, 2015-2020 (Million USD)
Table Global Liposome Drug Delivery Production Volume by Type, 2015-2020 (Volume)
Table Global Liposome Drug Delivery Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Liposome Drug Delivery Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Liposome Drug Delivery Consumption Value by Region, 2015-2020 (Million USD)
Table Global Liposome Drug Delivery Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Liposome Drug Delivery Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Liposome Drug Delivery Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Liposome Drug Delivery Revenue by Type, 2015-2020 (Million USD)
Table Europe Liposome Drug Delivery Production Volume by Type, 2015-2020 (Volume)
Table Europe Liposome Drug Delivery Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Liposome Drug Delivery Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Liposome Drug Delivery Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Liposome Drug Delivery Consumption Volume by Region, 2015-2020 (Volume)
Table America Liposome Drug Delivery Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Liposome Drug Delivery Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Liposome Drug Delivery Revenue by Type, 2015-2020 (Million USD)
Table America Liposome Drug Delivery Production Volume by Type, 2015-2020 (Volume)
Table America Liposome Drug Delivery Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Liposome Drug Delivery Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Liposome Drug Delivery Consumption Value by Region, 2015-2020 (Million USD)
Table America Liposome Drug Delivery Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Liposome Drug Delivery Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Liposome Drug Delivery Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Liposome Drug Delivery Revenue by Type, 2015-2020 (Million USD)
Table Asia Liposome Drug Delivery Production Volume by Type, 2015-2020 (Volume)
Table Asia Liposome Drug Delivery Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Liposome Drug Delivery Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Liposome Drug Delivery Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Liposome Drug Delivery Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Liposome Drug Delivery Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Liposome Drug Delivery Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Liposome Drug Delivery Revenue by Type, 2015-2020 (Million USD)
Table Oceania Liposome Drug Delivery Production Volume by Type, 2015-2020 (Volume)
Table Oceania Liposome Drug Delivery Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Liposome Drug Delivery Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Liposome Drug Delivery Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Liposome Drug Delivery Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Liposome Drug Delivery Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Liposome Drug Delivery Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Liposome Drug Delivery Revenue by Type, 2015-2020 (Million USD)
Table Africa Liposome Drug Delivery Production Volume by Type, 2015-2020 (Volume)
Table Africa Liposome Drug Delivery Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Liposome Drug Delivery Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Liposome Drug Delivery Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Liposome Drug Delivery Consumption Volume by Region, 2015-2020 (Volume)
Table Global Liposome Drug Delivery Revenue by Type, 2020E-2025F (Million USD)
Table Global Liposome Drug Delivery Production Volume by Type, 2020E-2025F (Volume)
Table Global Liposome Drug Delivery Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Liposome Drug Delivery Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Liposome Drug Delivery Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Liposome Drug Delivery Consumption Volume by Region, 2020E-2025F (Volume)
Table Johnson & Johnson Overview List
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Sciences Overview List
Table Business Operation of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pacira Overview List
Table Business Operation of Pacira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sun Pharmaceutical Overview List
Table Business Operation of Sun Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Luye Pharma Overview List
Table Business Operation of Luye Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sigma-Tau Group Overview List
Table Business Operation of Sigma-Tau Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Overview List
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ipsen (Onivyde) Overview List
Table Business Operation of Ipsen (Onivyde) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Fudan-Zhangjiang Overview List
Table Business Operation of Fudan-Zhangjiang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSPC Overview List
Table Business Operation of CSPC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kingond Pharm Overview List
Table Business Operation of Kingond Pharm (Sales Revenue, Cost, Gross Margin)
Table Shanghai New Asia Overview List
Table Business Operation of Shanghai New Asia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Spectrum Pharmaceuticals Overview List
Table Business Operation of Spectrum Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Global Liposome Drug Delivery Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Liposome Drug Delivery Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Liposome Drug Delivery Sales Volume by Companies, 2015-2020E (Volume)
Table Global Liposome Drug Delivery Sales Volume Share by Companies, 2015-2020E (Volume)

List of Figures

Figure Europe Liposome Drug Delivery Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Liposome Drug Delivery Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Liposome Drug Delivery Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Liposome Drug Delivery Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Liposome Drug Delivery Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaLiposome Drug Delivery Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Liposome Drug Delivery Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Liposome Drug Delivery Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Liposome Drug Delivery Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Liposome Drug Delivery Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Liposome Drug Delivery Revenue Share by Type in 2020 (Million USD)
Figure Global Liposome Drug Delivery Production Volume Share by Type in 2020 (Volume)
Figure Global Liposome Drug Delivery Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Liposome Drug Delivery Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Liposome Drug Delivery Revenue Share by Type in 2020 (Million USD)
Figure Europe Liposome Drug Delivery Production Volume Share by Type in 2020 (Volume)
Figure Europe Liposome Drug Delivery Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Liposome Drug Delivery Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Liposome Drug Delivery Revenue Share by Type in 2020 (Million USD)
Figure America Liposome Drug Delivery Production Volume Share by Type in 2020 (Volume)
Figure America Liposome Drug Delivery Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Liposome Drug Delivery Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Liposome Drug Delivery Revenue Share by Type in 2020 (Million USD)
Figure Asia Liposome Drug Delivery Production Volume Share by Type in 2020 (Volume)
Figure Asia Liposome Drug Delivery Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Liposome Drug Delivery Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Liposome Drug Delivery Revenue Share by Type in 2020 (Million USD)
Figure Oceania Liposome Drug Delivery Production Volume Share by Type in 2020 (Volume)
Figure Oceania Liposome Drug Delivery Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Liposome Drug Delivery Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Liposome Drug Delivery Revenue Share by Type in 2020 (Million USD)
Figure Africa Liposome Drug Delivery Production Volume Share by Type in 2020 (Volume)
Figure Africa Liposome Drug Delivery Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Liposome Drug Delivery Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Liposome Drug Delivery Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Liposome Drug Delivery Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Liposome Drug Delivery Revenue Share by Type in 2025 (Million USD)
Figure Global Liposome Drug Delivery Production Volume Share by Type in 2025 (Volume)
Figure Global Liposome Drug Delivery Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Liposome Drug Delivery Consumption Value Share by Region in 2025 (Million USD)
Figure Global Liposome Drug Delivery Consumption Volume Share by Region in 2025 (Volume)
  • Global Gold Nanoparticles Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121
    Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......
  • Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......
  • Global Gold Nanoparticles Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......
  • Global Liposome Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123
    According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......
  • Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......
  • Global Liposomes Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......
  • Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129
    According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......
  • Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
  • Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs